The diabetes medication that could revolutionise heart failure treatment

Published by  News Archive

On 1st Dec 2021

Blue and white pills falling onto a flat surface.

A medication originally used for patients with diabetes is the first to help people with heart failure and could revolutionise treatment, according to new research from the University of East Anglia.

Early research had shown that Sodium-glucose co-transporter-2 (SGLT2) inhibitors could help around half of heart failure patients – those with a condition known as reduction ejection fraction.

But new findings published today show that the medication could be beneficial for all heart failure patients – including those with a second type of heart failure called preserved ejection fraction.

It is the first drug to provide a real benefit in terms of improving outcomes for these patients. And the research team say it will revolutionise treatment options.

Lead researcher Prof Vass Vassiliou, from UEA’s Norwich Medical School and an Honorary Consultant Cardiologist at the Norfolk and Norwich University Hospital, said: “Heart failure is a condition where the heart is not pumping as well as it should, and it affects about one million people in the UK.

“There are two types of heart failure. Heart Failure with a reduction in ejection fraction happens when the heart is unable to pump blood round the body due to a mechanical issue. And heart failure with preserved ejection fraction happens when, despite the heart pumping out blood well, it is not sufficient to provide oxygen to all the parts of the body.

“Patients are equally split between the two types of heart failure.

“For many years there was not a single medicine that could improve the outcome in patients with the second type of heart failure – those patients with preserved ejection fraction.

“This type of heart failure had puzzled doctors, as every medicine tested showed no benefit.

“One class of heart medication, called SGLT2 inhibitors, was initially used for patients with diabetes. However, it was noticed that it also helped patients who had heart failure.

“Previous studies had shown that this medication would be beneficial in heart failure with reduced ejection fraction.

“But we found that it can also help heart failure patients with preserved ejection fraction.”

SGLT2 inhibitors are more commonly known under their trade-names Forxiga (Dapagliflozin), Invokana (Canagliflozin), and Jardiance (Empagliflozin).

The research team undertook a meta-analysis of all studies published in the field and brought together data from almost 10,000 patients. They used statistical modelling to show the specific effect of these medicines.

Prof Vassiliou said: “We found that patients taking SGLT2 inhibitors were 22 per cent less likely to die from heart-related causes or be hospitalised for heart failure exacerbation than those taking placebo.

“This is very important because this is the first medication that can provide a benefit to this previously untreatable group of patients - in terms of heart-related deaths or hospitalisation.

“This is the first medication that can really improve the outcomes for this patient group and it will revolutionise the treatment offered to heart failure patients,” he added.

This study was led by researchers at UEA in collaboration with the Norfolk and Norwich University Hospital, Imperial College London and Imperial College NHS Trust, and Cambridge University Hospitals.

‘Sodium Glucose Co-transporter 2 (SGLT2) inhibitors in Heart Failure with Preserved Ejection Fraction: A systematic review and meta-analysis’ is published in the European Journal of Preventive Cardiology on December 1, 2021.

Latest News

 
Light rays in purple.
04 Oct 2023

How quantum light sees quantum sound

Researchers at the University of East Anglia have proposed a new way of using quantum light to ‘see’ quantum sound.

Read more >
 
03 Oct 2023

Explore sixty years of UEA memories

In celebration of UEA’s 60th birthday, we take a look back at people’s happy memories of days past and look forward to decades more to come.

Read more >
 
Indian fisherman handling a net on the beach.
02 Oct 2023

Family networks improve outcomes for internal migration

Small-scale fishers in India could be benefiting from increase in forced migration - new research from UEA.

Read more >
 
Dr Naomi Wood pictured alongside her book titled 'This is Why We Can't Have Nice Things'
28 Sep 2023

Dr Naomi Wood wins the BBC National Short Story Awards

UEA Creative Writing lecturer and bestselling author, Dr Naomi Wood has been crowned the winner of the eighteenth BBC National Short Story Awards for her work...

Read more >
Are you searching for something?
 
Dr Naomi Wood pictured alongside her book titled 'This is Why We Can't Have Nice Things'
28 Sep 2023

Dr Naomi Wood wins the BBC National Short Story Awards

UEA Creative Writing lecturer and bestselling author, Dr Naomi Wood has been crowned the winner of the eighteenth BBC National Short Story Awards for her work...

Read more >
 
A woman in football kit
25 Sep 2023

From Psychology to the Canaries: UEA student on target for Norwich City Women’s Football Club

A University of East Anglia Psychology student has marked her fledgling Norwich City Women’s Football Club career with a quick-fire hat-trick in one of her first...

Read more >
 
A nurse interacting with a patient.
21 Sep 2023

Nurses worldwide rely on intuition to triage patients

Nurses around the world use intuition to work out how sick a patient is before triaging for treatment – according to new research from the University of East...

Read more >
 
Francessca Turrell
18 Sep 2023

UEA nursing apprentice’s sky-high dive for Alzheimer's and Dementia awareness

On Sunday 24 September, University of East Anglia (UEA) nursing apprentice Francessca Turrell will be taking part in a charity skydive for Alzheimer’s Society, a...

Read more >
 
Logo Rewind's yellow book cover with black symbols
14 Sep 2023

New book to focus on Norwich’s medieval logos

‘Logo Rewind: Trademarks of Medieval Norwich’ is a new book from UEA Publishing Project, in collaboration with CreativeUEA and featuring the work of Darren...

Read more >
 
Ziggurats
13 Sep 2023

UEA students discover new room location following RAAC accommodation closures

Over 700 University of East Anglia (UEA) students have discovered where their new university homes will be located, following the closure of some accommodation...

Read more >
 
(L-R) Chris Law MP, Dr Martin Scott, Renu Mehta
13 Sep 2023

New report from UEA Academic asks whether UK Aid Match has been used for ‘charity washing’, ahead of Westminster event

A new report from the University of East Anglia’s Dr Martin Scott into the Government’s UK Aid Match (UKAM) scheme has led to concerns of ‘charity washing’, with...

Read more >